Click to bigify
LONDON, Feb 26 (Reuters) - Britain's state health service should ditch some drugs that are not worth using, including AstraZeneca's (AZN.L) top-seller Nexium for heartburn, to provide funds for new treatments, experts said on Friday.
Dyfrig Hughes of Bangor University and Robin Ferner of Birmingham's City Hospital said such medicines could be relegated to a blacklist of products that cannot be prescribed on the National Health Service (NHS).
Their suggestion, in an article in the British Medical Journal, underscores a growing debate over value for money in healthcare.
Britain's National Institute for Health and Clinical Excellence (NICE) has taken a global lead by recommending which drugs should be reimbursed on the NHS, using a systemised approach that is watched closely by other countries. Continued...
1 comment:
Nexium (Esomeprazole) fits in the class of drugs known as proton pump inhibitors. This medication is used in the treatment of GERD (gastroesophageal reflux disease) and some other conditions caused by excess production of stomach acid. Nexium effectively decreases acid production in the stomach. Esomeprazole can also be used for healing esophagus damage brought on by stomach acid. Nexium reduces the risk of forming stomach ulcers caused by H. Pylori bacteria infections. This medication is not used for getting immediate relief from heartburn symptoms. Generic Nexium is available in tablet form.
Post a Comment